JPRN-jRCT2080220896未知2 期
Dose finding study of TAK-438 in patients with reflux esophagitis (phase II study)
适应症
试验速览
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 ot applicable（—）
- 性别
- All
入选标准
- •1. Endoscopic diagnosis of grade A to D reflux esophagitis by LA classification at the start of the follow-up period (visit 1), etc.
排除标准
- •1. Complications that may affect the esophagus, history of esophageal radiotherapy or cryotherapy, or presence of corrosive or physiochemical trauma
- •2. History of surgery for reflux esophagitis, dilation of esophageal stricture, or surgery of the stomach or duodenum
- •3. Acute upper gastrointestinal bleeding or active gastric or duodenal ulcer within 30 days prior to the start of the follow-up period, etc.
研究者
相似试验
未知
1 期
A Phase I Multiple Administration Study of TAK-448 in Patients with Prostate CancerProstate CancerJPRN-jRCT2080220949Takeda Pharmaceutical Company Limited
已完成
1 期
TAK-438 - Safety, Blood Levels & Effects of Repeated DosesErosive Esophagitis(EE)Gastroesophageal Reflux Disease (GERD)NCT02141711Takeda48
未知
3 期
An open-label study of TAK-536 in patients with grade III hypertensioHypertensionJPRN-jRCT2080220836Takeda Pharmaceutical Company Limited
已完成
3 期
Efficacy of TAK-438 Compared to AG-1749 (Lansoprazole) in the Treatment of Gastric UlcerGastric UlcerNCT01452711Takeda482
已完成
1 期
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of TAK-438 in Healthy Male ParticipantsDose Finding StudyNCT02123953Takeda60